TY - JOUR
T1 - Retos y perspectivas de las agencias de evaluación de Tecnologías en Salud en el Perú
AU - Díaz-Vélez, Cristian
AU - Peña-Sánchez, Ricardo
AU - Galán-Rodas, Edén
AU - Apolaya-Segura, Moisés
AU - Herrera-Añazco, Percy
AU - Molineli-Aristondo, Fiorela
N1 - Publisher Copyright:
© 2023 Medical Body of the Almanzor Aguinaga Asenjo National Hospital. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Background: Health Technologies (HT) are important to make appropriate decisions in the field of health. The need to standardize TS evaluations is highlighted, since there are currently differences in the methods and recommendations used. In addition, the lack of trained human resources to carry out these evaluations is mentioned, as well as the long times they can take. Therefore, it is essential to prioritize the technologies to be evaluated to maximize available resources. In Latin America, the health technology prioritization process presents various barriers, such as the lack of an explicit and formal prioritization process in most countries. These barriers include fragmentation of health services, disagreement among stakeholders, and fear of reduced discretion in decision-making. Despite these difficulties, prioritization processes have been developed based on different methodological frameworks, which must be transparent, systematic, efficient, explicit and consensual. Therefore, it is necessary to have reference frameworks to evaluate the impact of these technologies on healthcare. The importance of declaring conflicts of interest in the evaluation of health technologies and how industry influence can affect the evaluation process is highlighted. Furthermore, the need to standardize evaluation methodologies and instruments is highlighted to improve the quality and comparability of STDs.
AB - Background: Health Technologies (HT) are important to make appropriate decisions in the field of health. The need to standardize TS evaluations is highlighted, since there are currently differences in the methods and recommendations used. In addition, the lack of trained human resources to carry out these evaluations is mentioned, as well as the long times they can take. Therefore, it is essential to prioritize the technologies to be evaluated to maximize available resources. In Latin America, the health technology prioritization process presents various barriers, such as the lack of an explicit and formal prioritization process in most countries. These barriers include fragmentation of health services, disagreement among stakeholders, and fear of reduced discretion in decision-making. Despite these difficulties, prioritization processes have been developed based on different methodological frameworks, which must be transparent, systematic, efficient, explicit and consensual. Therefore, it is necessary to have reference frameworks to evaluate the impact of these technologies on healthcare. The importance of declaring conflicts of interest in the evaluation of health technologies and how industry influence can affect the evaluation process is highlighted. Furthermore, the need to standardize evaluation methodologies and instruments is highlighted to improve the quality and comparability of STDs.
KW - Biomedical Technology
KW - Health Evaluation
KW - Peru. (Source: DeCS-BIREME)
KW - Technology Assessment, Biomedical
UR - http://www.scopus.com/inward/record.url?scp=85190244530&partnerID=8YFLogxK
U2 - 10.35434/rcmhnaaa.2023.162.1704
DO - 10.35434/rcmhnaaa.2023.162.1704
M3 - Artículo de revisión
AN - SCOPUS:85190244530
SN - 2225-5109
VL - 16
JO - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
JF - Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
IS - 2
ER -